GZI CEO Sean Adler to be Listed in the “Top 10 Most Influential Leaders in Biotechnology”, GZI Finalizes $250k Reg CF Offering with Netcapital, Live MVP, and More Goodies

The team at GZI is pleased to announce their CEO, Sean Adler, will be listed in Beyond Exclamation magazine as one of the “Top 10 Most Influential Leaders in Biotechnology”. We are honored to have additional media coverage and look forward to syndicating the news across the channels of our existing and future partners.

GZI has finalized our contract with a Top 5 Reg CF platform, Netcapital, for a $250k offering. GZI has the option to relist for the remaining $750k but is still in negotiations with additional partners and cannot confirm the entire offering until negotiations are finished. This would not have been possible without everyone’s continuous support and we will continue to provide updates as the offering progresses.

The first version of our MVP is now live and ready to serve customers with the same trading data that outperformed 103/107 of Wall St.’s largest hedge funds in 2020 and netted us 30% as of June 2021. Please contact us if our product falls short of your expectations and we will revise accordingly.